benefits and costs of newer drugs
Subtitle: evidence from the 1996 Medical Expenditure Panel Survey
By: Frank R. Lichtenberg.
Contributors: National Bureau of Economic Research.
Series: NBER working paper series -- no. 8147; Working paper series (National Bureau of Economic Research) -- working paper no. 8147.
Publisher: National Bureau of Economic Research
Published: 2001
Place of publication: Cambridge, MA
Language: eng
Number of pages: 40
Subjects: Pharmaceutical industry -- Research -- United States.; Prescription pricing -- United States.; Drugs -- Research -- United States.
Other titles: Evidence from the 1996 Medical Expenditure Panel Survey
Notes: "March 2001."

JEL no. I1, L65, O3.

Includes bibliographical references (p. 21-22).

Electronic access limited to Binghamton University faculty, staff and students for instructional and research purposes only.

Electronic version available via the Internet at the NBER World Wide Web site.